A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer
Clinical trial NCT02898077 · COMPLETED
Trial details
- NCT number
- NCT02898077
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-02
- Primary completion
- 2020-06-30
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.